Videos: Hereditary Hemochromatosis
2020 Membership Lecture Series Guest Lecturer: Prof. Pierre Brissot
On June 17, 2020, the Canadian Hemochromatosis Society presented its first online information session in its Membership Lecture Series. We were honoured to have Prof. Pierre Brissot join us live from Rennes, France, to provide us with an updated view on the definition, diagnosis and treatment for hemochromatosis in 2020.
Pierre Brissot is a Professor Emeritus of Medicine ; Member of the French National Academy of Medicine ; Past-President of the International BioIron Society ; Founder or Co-founder of FFAMH (Fédération Française des Associations de Malades de l’Hémochromatose), EFAPH (European Federation of Associations of Patients with Haemochromatosis), and HI (Haemochromatosis International).
Thank you to Prof. Brissot, and Canadian Hemochromatosis Society members and supporters for making this presentation possible.
2016 Guest Lecturer: Dr. Paul Adams
In October 2016, the Canadian Hemochromatosis Society held an Information Session in Guelph, Ontario, featuring Dr. Paul Adams, Professor of Medicine and Chief of Gastroenterology, University of Western Ontario. The Canadian Hemochromatosis Society recorded this session and presents it here in a series of 8 videos that cover a wide range of topics from ancestral links to research, diagnosis, treatment, ferritin and diet.
Special acknowledgements and thanks to Dr. Paul Adams and to James Brodie Productions for producing these videos.
1. Ancestral Links
In this video segment, Dr. Adams speaks on the possible origins of the hemochromatosis gene, its migration and its modern day prevalence.
In this proviso to the upcoming video segments, Dr. Adams discusses the degree of uncertainty related to science and medicine, and the various approaches to diagnose and treat hemochromatosis.
Dr. Paul Adams goes into the discovery of the C282Y gene, symptoms of hemochromatosis, the reasons there is no mass population screening, and lessons learned from the HEIRS (Hemochromatosis and Iron-Overload Screening) study.
Dr. Adams presents the familial risks of hemochromatosis and the potential stigmatization that arises from genetically testing children.
Dr. Adams discusses how diagnoses are generally made…. and why some are missed. Also: what do most people have when their ferritin levels are found to be between 300 and 1000 ng/mL? Hemochromatosis surprisingly does NOT top the list.
6. Ferritin Tests
Here, Dr. Adams answers audience questions on ferritin, iron overload and liver biopsies.
Scarring of the liver caused by iron overload can be reversed by treatment with phlebotomies, but Dr. Adams explains why many do not see improvement of joint pain. Also, Dr. Adams discusses situations where some individuals do not require maintenance once de-ironed.
Dr. Adams discusses hepcidin’s role in regulating body’s iron balance and the effects of diet in hemochromatosis.